EU Explains Plans To Speed Up Variant Vaccine Approvals

New EMA Expert Group Will Probe AZ Vaccine Blood Clot Issue

 
• By Ian Schofield

The EU institutions are taking steps to preserve the effectiveness of existing vaccines in the face of mutations in the SARS-CoV-2 virus.

Mutating virus concept and new coronavirus variant outbreak or covid-19 viral cell mutation and influenza background as dangerous flu strain medical health risk with disease cells as a 3D render.
Variants of the coronavirus are causing a surge in infections in Europe • Source: Shutterstock

More from Europe

More from Geography